| Epigenetic mechanisms in metal toxicity D Fragou, A Fragou, S Kouidou, S Njau, L Kovatsi Toxicology mechanisms and methods 21 (4), 343-352, 2011 | 104 | 2011 |
| CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides AO Docea, L Vassilopoulou, D Fragou, AL Arsene, C Fenga, L Kovatsi, ... Toxicology reports 4, 335-341, 2017 | 79 | 2017 |
| The association of female and male infertility with telomere length E Vasilopoulos, P Fragkiadaki, C Kalliora, D Fragou, AO Docea, ... International journal of molecular medicine 44 (2), 375-389, 2019 | 73 | 2019 |
| Smoking and DNA methylation: correlation of methylation with smoking behavior and association with diseases and fetus development following prenatal exposure D Fragou, E Pakkidi, M Aschner, V Samanidou, L Kovatsi Food and Chemical Toxicology 129, 312-327, 2019 | 51 | 2019 |
| Novel strategies for sample preparation in forensic toxicology V Samanidou, L Kovatsi, D Fragou, K Rentifis Bioanalysis 3 (17), 2019-2046, 2011 | 46 | 2011 |
| Effect of chronic heroin and cocaine administration on global DNA methylation in brain and liver D Fragou, P Zanos, S Kouidou, S Njau, I Kitchen, A Bailey, L Kovatsi Toxicology letters 218 (3), 260-265, 2013 | 40 | 2013 |
| Drugs of abuse: epigenetic mechanisms in toxicity and addiction L Kovatsi, D Fragou, V Samanidou, S Njau, S Kouidou Current medicinal chemistry 18 (12), 1765-1774, 2011 | 26 | 2011 |
| Alterations in serum MMP and TIMP concentrations following chronic heroin abuse L Kovatsi, S Batzios, K Nikolaou, D Fragou, S Njau, A Tsatsakis, ... Toxicology mechanisms and methods 23 (5), 377-381, 2013 | 20 | 2013 |
| Epigenetically modified nucleotides in chronic heroin and cocaine treated mice MR Chao, D Fragou, P Zanos, CW Hu, A Bailey, S Kouidou, L Kovatsi Toxicology letters 229 (3), 451-457, 2014 | 17 | 2014 |
| Worldwide legislative challenges related to psychoactive drugs C Negrei, B Galateanu, M Stan, C Balalau, MLB Dumitru, E Ozcagli, ... DARU Journal of Pharmaceutical Sciences 25, 1-7, 2017 | 16 | 2017 |
| Atypical antipsychotics: trends in analysis and sample preparation of various biological samples D Fragou, S Dotsika, P Sarafidou, V Samanidou, S Njau, L Kovatsi Bioanalysis 4 (8), 961-980, 2012 | 10 | 2012 |
| CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol Rep 4: 335–341 AO Docea, L Vassilopoulou, D Fragou, AL Arsene, C Fenga, L Kovatsi, ... | 9 | 2017 |
| Evaluation of 5-methyl-2-deoxycytidine stability in hydrolyzed and nonhydrolyzed DNA by HPLC–UV L Kovatsi, D Fragou, V Samanidou, S Njau, S Kouidou, A Bailey Bioanalysis 4 (4), 367-372, 2012 | 8 | 2012 |
| Ocular biomarkers in diseases and toxicities GA Kontadakis, D Fragou, A Plaka, AF Hernández, GD Kymionis, ... Biomarkers in Toxicology, 375-383, 2019 | 7 | 2019 |
| Global DNA methylation levels in white blood cells of patients with chronic heroin use disorder. A prospective study D Fragou, MR Chao, CW Hu, K Nikolaou, L Kovatsi Toxicology Reports 8, 337-342, 2021 | 4 | 2021 |
| Drugs of Abuse and DNA Methylation in the Brain: Ethanol, Cocaine, Amphetamine–Methamphetamine, Heroin, Antidepressants, and Antipsychotics D Fragou, L Kovatsi Neuropathology of Drug Addictions and Substance Misuse, 137-143, 2016 | 2 | 2016 |
| Epigenetic fingerprint L Kovatsi, A Vidaki, D Fragou Personalized Epigenetics, 221-243, 2015 | 2 | 2015 |
| Recent advances in the bioanalysis of modified nucleotides in epigenetic studies D Fragou, A Fragou, V Samanidou, S Kouidou, S Njau, L Kovatsi Bioanalysis 5 (23), 2947-2956, 2013 | 2 | 2013 |
| Epigenetic mechanisms in nanomaterial toxicity D Fragou, L Kovatsi Toxicological Risk Assessment and Multi-System Health Impacts from Exposure …, 2021 | | 2021 |
| Monitoring the transition from cigarette smoking to vaping using exposure, biochemical, brain dynamics and psychometric markers: The SmokeFreeBrain Study T Marczylo, E Zhuikova, N Goldsmith, E Macauley, P Durrant, H Goss, ... Tobacco Prevention & Cessation 4 (Supplement), 2018 | | 2018 |
